Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
104 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02821559 | Biweekly Versus Triweekly Raltitrexed With Oxaliplatin (With or Without Bevacizumab) in First-line Metastatic Colorectal Cancer(EROS) | completed | Phase 2 | 37 | Centre Hospitalier Universitaire de BesanconOTHER | 1 | Jul 23, 2026 | clinicaltrials |
| NCT03117946 | Modulation of Anti-tumor T Cell Responses in Cancer Patients Treated by Concomitant Radiochemotherapy(i-RTCT) | completed | N/A | 136 | Centre Hospitalier Universitaire de Besancon |
| 1 |
| Jul 23, 2026 |
| clinicaltrials |
| NCT06796114 | Identification of Innovative Biomarkers to Predict Outcomes in Hepatocellular Carcinoma Treated With Tremelimumab and Durvalumab(PREDICT-HCC) | recruiting | N/A | 120 | Centre Hospitalier Universitaire de BesanconOTHER | 1 | Jul 23, 2026 | clinicaltrials |
| NCT07036380 | MP0317 in Combination With Chemoimmunotherapy in First Line Treatment for Patients With Advanced Biliary Tract Carcinoma(TACTIC) | recruiting | Phase 2 | 75 | Centre Hospitalier Universitaire de BesanconOTHER | 1 | Jun 1, 2026 | clinicaltrials |
| NCT04767568 | Exploratory Study of the Relevance of a Blood Test in the Management of Patients in the Context of Colorectal Cancer Screening(PREDICT-IRFC) | recruiting | N/A | 400 | Centre Hospitalier Universitaire de BesanconOTHER | 1 | Mar 16, 2026 | clinicaltrials |
| NCT05528952 | Evaluation of the Interest to Combine a CD4 Th1-inducer Cancer Vaccine Derived From Telomerase and Atezolizumab Plus Bevacizumab in Unresectable Hepatocellular Carcinoma(TERTIO) | recruiting | Phase 2 | 105 | Centre Hospitalier Universitaire de BesanconOTHER | 1 | Mar 16, 2026 | clinicaltrials |
| NCT02840058 | Interest of Anti-telomerase T CD4 Immune Responses for Predicting the Effectiveness of Immunotherapies Targeting PD1 / PDL1(ITHER) | completed | N/A | 295 | Centre Hospitalier Universitaire de BesanconOTHER | 1 | Mar 6, 2026 | clinicaltrials |
| NCT07347210 | Evaluation of UCPVax Vaccine +/- Pembrolizumab Combined With Standard Treatment as Adjuvant Therapy in Patients With Unmethylated MGMT Glioblastoma(MATVAC-1) | not yet recruiting | Phase 2 | 98 | Centre Hospitalier Universitaire de BesanconOTHER | 1 | Jan 16, 2026 | clinicaltrials |
| NCT05970471 | Preferences of Patients Treated With Oral Cancer Drugs and Informal Caregivers for Pharmaceutical Consultation in Hospital(IMPLICATION) | completed | — | 167 | Centre Hospitalier Universitaire de BesanconOTHER | 1 | Dec 12, 2025 | clinicaltrials |
| NCT07124403 | DESIR. Evaluation of the Pre-therapeutic Activity of Dihydropyrimidine dEShydrogenase (DPD) in Patients With Cancer and/or Renal Failure(DESIR) | not yet recruiting | — | 742 | Centre Hospitalier Universitaire de BesanconOTHER | 0 | Sep 17, 2025 | clinicaltrials |
| NCT02849886 | T Lymphocytes (LT) Expressing iCASP9 and ΔCD19 in Allogeneic Haematopoietic Transplantation.(Side_by_Cide) | terminated | Phase 1 / Phase 2 | 2 | Centre Hospitalier Universitaire de BesanconOTHER | 1 | Jul 9, 2025 | clinicaltrials |
| NCT05257707 | Molecular Markers in Cancers and Precancers (MOCA)(MOCA) | withdrawn | N/A | 0 | Centre Hospitalier Universitaire de BesanconOTHER | 1 | Jul 9, 2025 | clinicaltrials |
| NCT06805097 | Clinical Efficacy of Platelet Transfusion(ECLAT) | recruiting | — | 343 | Centre Hospitalier Universitaire de BesanconOTHER | 1 | Jul 9, 2025 | clinicaltrials |
| NCT06626269 | Identification of Innovative Biomarkers Related to the Immune System or Tumor Microenvironment to Promote the Efficacy of Immunotherapies(HORIZON) | recruiting | N/A | 700 | Centre Hospitalier Universitaire de BesanconOTHER | 1 | Jun 20, 2025 | clinicaltrials |
| NCT02842333 | Study of Predictive Immunological Parameters of Molecular Complete Remission in Patients With Chronic Myelogenous Leukemia in Chronic Phase and Treated With Tyrosine Kinase Inhibitor(PAMIR01) | completed | N/A | 57 | Centre Hospitalier Universitaire de BesanconOTHER | 1 | May 25, 2025 | clinicaltrials |
| NCT06910280 | Evaluation of the Feasibility of a Study Comparing Local Anesthesia and General Anesthesia in Conservative Surgery for Breast Cancer(ESCAL) | not yet recruiting | N/A | 60 | Centre Hospitalier Universitaire de BesanconOTHER | 1 | Apr 4, 2025 | clinicaltrials |
| NCT02861430 | Ex-vivo Sentinel Lymph Node in Stage I-II Colon Cancer: Kappa Analysis With Immunochemistry and Molecular Biology(UNMASK) | completed | — | 48 | Centre Hospitalier Universitaire de BesanconOTHER | 1 | Feb 11, 2025 | clinicaltrials |
| NCT03117972 | Chemotherapy Intensification in Patients With High Lactate Dehydrogenase Values and Soluble Syndecan1 Levels(CLavSyn) | terminated | Phase 2 | 54 | Centre Hospitalier Universitaire de BesanconOTHER | 1 | Feb 5, 2025 | clinicaltrials |
| NCT04263051 | Evaluation of UCPVax Plus Nivolumab as Second Line Therapy in Advanced Non Small Cell Lung Cancer(Optim-UCPVax) | completed | Phase 2 | 60 | Centre Hospitalier Universitaire de BesanconOTHER | 1 | Feb 5, 2025 | clinicaltrials |
| NCT02818426 | Universal Cancer Peptide-based Vaccination in Metastatic NSCLC(UCPVax) | completed | Phase 1 / Phase 2 | 82 | Centre Hospitalier Universitaire de BesanconOTHER | 1 | Jan 9, 2025 | clinicaltrials |
| NCT04280848 | Anticancer Therapeutic Vaccination Using Telomerase-derived Universal Cancer Peptides in Glioblastoma(UCPVax-Glio) | completed | Phase 2 | 67 | Centre Hospitalier Universitaire de BesanconOTHER | 1 | Jan 9, 2025 | clinicaltrials |
| NCT02838381 | Study of Genetic and Cellular Immunological Parameters Predictive of Disease-free Survival in Patients With Metastatic Cancer(Epitopes-CRC01) | completed | N/A | 553 | Centre Hospitalier Universitaire de BesanconOTHER | 1 | Dec 27, 2024 | clinicaltrials |
| NCT02839291 | Evaluation of Medical Practice in the Management of Bone Metastases After Injectable Bone Antiresorptive Treatment, and Its Influence on Quality of Life(PRISM) | active not recruiting | N/A | 148 | Centre Hospitalier Universitaire de BesanconOTHER | 1 | Dec 27, 2024 | clinicaltrials |
| NCT06425133 | Regorafenib in Combination With Multimodal Metronomic Chemotherapy for Chemo-resistant Metastatic Colorectal Cancers(CARE) | recruiting | Phase 2 | 174 | Centre Hospitalier Universitaire de BesanconOTHER | 1 | Dec 24, 2024 | clinicaltrials |
| NCT03946358 | Combination of UCPVax Vaccine and Atezolizumab for the Treatment of Human Papillomavirus Positive Cancers (VolATIL)(VolATIL) | completed | Phase 2 | 47 | Centre Hospitalier Universitaire de BesanconOTHER | 1 | Dec 20, 2024 | clinicaltrials |
| NCT04534218 | Regorafenib in Combination With Metronomic Chemotherapies, and Low-dose Aspirin in Metastatic Colorectal Cancer(REPROGRAM-01) | completed | Phase 2 | 49 | Centre Hospitalier Universitaire de BesanconOTHER | 1 | Dec 20, 2024 | clinicaltrials |
| NCT04719988 | Anti-PD-1 and mDCF Followed by Chemoradiotherapy in Patients With Stage III Squamous Cell Anal Carcinoma.(INTERACT-ION) | active not recruiting | Phase 2 | 55 | Centre Hospitalier Universitaire de BesanconOTHER | 1 | Dec 20, 2024 | clinicaltrials |
| NCT05462613 | Regorafenib With Low-dose Chemotherapies and Aspirin Followed by Standard Chemotherapies in Metastatic Colorectal Cancer(REPROGRAM-02) | recruiting | Phase 2 / Phase 3 | 446 | Centre Hospitalier Universitaire de BesanconOTHER | 1 | Dec 20, 2024 | clinicaltrials |
| NCT05333367 | MORPHEE : Mechanisms of Cell Death Induced by Extracorporeal Photochemotherapy(MORPHEE) | recruiting | N/A | 20 | Centre Hospitalier Universitaire de BesanconOTHER | 1 | Nov 21, 2024 | clinicaltrials |
| NCT02818907 | Evaluation of Survival Prognostic Factors for Patients With Exocrine Pancreatic Cancer Resectable or Potentially Resectable(Pancreas-CGE) | completed | N/A | 290 | Centre Hospitalier Universitaire de BesanconOTHER | 1 | Sep 19, 2024 | clinicaltrials |
| NCT05168839 | Intraoperative Indocyanine Green Fluorescence Angiography in Colorectal Surgery to Prevent Anastomotic Leakage(FLUOCOL-1) | recruiting | Phase 3 | 1,010 | Centre Hospitalier Universitaire de BesanconOTHER | 1 | Sep 19, 2024 | clinicaltrials |
| NCT06112509 | Evolution of Vestibular Function After Treatment of a Vestibular Schwannoma by Gamma-knife Radio-surgery(EVERS) | recruiting | N/A | 20 | Centre Hospitalier Universitaire de BesanconOTHER | 1 | Sep 19, 2024 | clinicaltrials |
| NCT06586580 | Treatment of Metastatic Melanoma with Lenvatinib + Anti-PD1(LENVAMEL) | completed | — | 18 | Centre Hospitalier Universitaire de BesanconOTHER | 1 | Sep 19, 2024 | clinicaltrials |
| NCT06586593 | Neoadjuvant Immunotherapy of Operable Metastatic Melanoma in Real Life (GCC)(NEOMEL) | recruiting | — | 77 | Centre Hospitalier Universitaire de BesanconOTHER | 1 | Sep 19, 2024 | clinicaltrials |
| NCT03386734 | International Validation Study of Sentinel Node Biopsy in Early Cervical Cancer(SENTICOLIII) | active not recruiting | N/A | 989 | Centre Hospitalier Universitaire de BesanconOTHER | 14 | Jul 8, 2024 | clinicaltrials |
| NCT06337487 | Quality of Life Assessment for Early Identification of Supportive Care Needs in Oncology Patients(SOS-DETEQT) | unknown | N/A | 93 | Centre Hospitalier Universitaire de BesanconOTHER | 1 | Mar 29, 2024 | clinicaltrials |
| NCT06334406 | Antitumor T Cell Responses in Patients With Bladder Cancer(immunoBLAD) | unknown | — | 33 | Centre Hospitalier Universitaire de BesanconOTHER | 0 | Mar 28, 2024 | clinicaltrials |
| NCT06321744 | Study Evaluating the Feasibility of an Adapted Physical Activity Program During the Hospitalization Phase in Cancer Patients Undergoing Treatment(PREVAPA) | unknown | N/A | 32 | Centre Hospitalier Universitaire de BesanconOTHER | 0 | Mar 20, 2024 | clinicaltrials |
| NCT04169022 | AML Cell Immunotherapy Using Chimeric Antigen Receptor T-cells(CAR-LAM) | completed | N/A | 86 | Centre Hospitalier Universitaire de BesanconOTHER | 1 | Feb 12, 2024 | clinicaltrials |
| NCT03599960 | Combination Chemotherapy in Patients With Newly Diagnosed BPDCN(LpDessai) | unknown | Phase 2 | 26 | Centre Hospitalier Universitaire de BesanconOTHER | 1 | Feb 8, 2024 | clinicaltrials |
| NCT05593718 | Comparison of HFNO and FMV on Desaturations During Panendoscopy Under General Anesthesia | unknown | — | 450 | Centre Hospitalier Universitaire de BesanconOTHER | 1 | Feb 7, 2024 | clinicaltrials |
| NCT05601570 | Impact of the Experience of Anaesthetists in Changing Ventilation Strategies During Panendoscopy on the Incidence of Intraoperative Hypoxaemia | unknown | — | 850 | Centre Hospitalier Universitaire de BesanconOTHER | 1 | Feb 7, 2024 | clinicaltrials |
| NCT06216990 | Metastatic or Refractory Soft Tissue Sarcomas and Metronomic Cyclophosphamide: Further Assessment of Efficacy and Safety(MeRCY) | completed | — | 60 | Centre Hospitalier Universitaire de BesanconOTHER | 0 | Jan 22, 2024 | clinicaltrials |
| NCT02735057 | Chemoradiotherapy in Elderly Patients With Oesophagus Cancer(OSAGE) | recruiting | Phase 1 / Phase 2 | 54 | Centre Hospitalier Universitaire de BesanconOTHER | 1 | Jan 18, 2024 | clinicaltrials |
| NCT06185569 | FREDO-ODX Study: FREnch Data on Outcomes in HR+/HER2- Early Breast Cancer Patients With oncotypeDX Recurrence Score-guided Therapy(FREDO-ODX-23) | recruiting | — | 4,500 | Centre Hospitalier Universitaire de BesanconOTHER | 1 | Dec 29, 2023 | clinicaltrials |
| NCT04894370 | Combination of Spartalizumab, mDCF and Radiotherapy in Patients With Metastatic Squamous Cell Anal Carcinoma(SPARTANA) | recruiting | Phase 2 | 34 | Centre Hospitalier Universitaire de BesanconOTHER | 1 | Dec 22, 2023 | clinicaltrials |
| NCT06101732 | LIMBO : Breast Reconstruction by Lipomodeling Alone or With Flap: Evaluation in Franche-Comté(LIMBO) | completed | — | 140 | Centre Hospitalier Universitaire de BesanconOTHER | 1 | Oct 27, 2023 | clinicaltrials |
| NCT02626377 | Multicenter Prospective Cohort of Informal Caregivers in Burgundy and Franche-Comté(ICE) | terminated | N/A | 186 | Centre Hospitalier Universitaire de BesanconOTHER | 1 | Oct 23, 2023 | clinicaltrials |
| NCT02846103 | Study of Anti-telomerase T CD4 Immunity in Metastatic Lung Cancer(Telocap02) | completed | N/A | 321 | Centre Hospitalier Universitaire de BesanconOTHER | 1 | Sep 18, 2023 | clinicaltrials |
| NCT04488874 | Sodium Lactate and Brain Relaxation (LSD)(LSD) | completed | Phase 3 | 50 | Centre Hospitalier Universitaire de BesanconOTHER | 1 | Sep 13, 2023 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials